Solventum Corporation
SOLV
$70.40
-$0.41-0.58%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.86% | 2.28% | 2.21% | 1.29% | 0.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.86% | 2.28% | 2.21% | 1.29% | 0.70% |
| Cost of Revenue | 6.15% | 6.92% | 7.19% | 7.77% | 3.94% |
| Gross Profit | -3.32% | -1.32% | -1.56% | -3.47% | -1.73% |
| SG&A Expenses | 12.69% | 19.91% | 25.55% | 29.26% | 22.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.54% | 10.78% | 12.97% | 14.44% | 10.02% |
| Operating Income | -42.91% | -43.17% | -44.83% | -48.83% | -35.25% |
| Income Before Tax | 182.67% | 69.79% | -75.53% | -80.71% | -63.65% |
| Income Tax Expenses | 23.62% | -44.87% | -122.48% | -118.66% | -60.44% |
| Earnings from Continuing Operations | 224.84% | 111.67% | -64.08% | -70.62% | -64.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 224.84% | 111.67% | -64.08% | -70.62% | -64.41% |
| EBIT | -42.91% | -43.17% | -44.83% | -48.83% | -35.25% |
| EBITDA | -32.46% | -31.59% | -33.89% | -37.27% | -26.72% |
| EPS Basic | 222.55% | 110.04% | -64.28% | -70.75% | -64.48% |
| Normalized Basic EPS | -58.34% | -67.34% | -69.01% | -75.91% | -60.01% |
| EPS Diluted | 221.48% | 109.37% | -64.50% | -70.92% | -64.56% |
| Normalized Diluted EPS | -58.54% | -67.52% | -69.15% | -76.00% | -60.07% |
| Average Basic Shares Outstanding | 0.55% | 0.51% | 0.48% | 0.42% | 0.28% |
| Average Diluted Shares Outstanding | 0.94% | 1.02% | 0.98% | 0.85% | 0.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |